Panoramic Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.81M Buy
5,231
+1,950
+59% +$1.98M 3.38% 11
2025
Q4
$3.53M Buy
3,281
+1,690
+106% +$1.62M 1.89% 18
2025
Q3
$1.21M Sell
1,591
-9
-0.6% -$6.7K 0.55% 37
2025
Q2
$1.25M Sell
1,600
-2,124
-57% -$1.65M 0.94% 31
2025
Q1
$3.08M Sell
3,724
-3,957
-52% -$3.29M 3.55% 9
2024
Q4
$5.93M Buy
+7,681
New +$6.36M 3.16% 6

Other funds holding LLY

Panoramic Capital's LLY Position: Q1 2026 in Review

Panoramic Capital increased its Eli Lilly (LLY) stake by 59% in Q1 2026, buying an estimated $1.98M and bringing the position to 5,231 shares worth $4.81M. The position accounts for 3.38% of the portfolio, ranked #11.

Panoramic Capital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.93M in Q4 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Panoramic Capital held 5,231 shares of Eli Lilly worth $4.81M as of Q1 2026.
  • Panoramic Capital bought 1,950 Eli Lilly shares in Q1 2026, an estimated $1.98M.
  • Eli Lilly made up 3.38% of Panoramic Capital's portfolio in Q1 2026, its #11 holding.
  • Panoramic Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Panoramic Capital's Eli Lilly position peaked at $5.93M in Q4 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Panoramic Capital's 13F filing for Q1 2026, filed 15 May 2026.